April 16, 2026
Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today an update related to: Femasys Shareholder Update – Q1 2026.
